Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BAX Baxter International Inc. daily Stock Chart
BAX [NYSE]
Baxter International Inc.
Healthcare | Medical Instruments & Supplies | USA
financial highlights | statements
IndexS&P 500 P/E38.65 EPS (ttm)1.64 Insider Own0.10% Shs Outstand547.94M Perf Week-1.46%
Market Cap34.73B Forward P/E23.76 EPS next Y2.67 Insider Trans-90.45% Shs Float544.16M Perf Month1.98%
Income904.00M PEG2.90 EPS next Q0.60 Inst Own87.80% Short Float1.05% Perf Quarter4.45%
Sales10.28B P/S3.38 EPS this Y21.90% Inst Trans0.71% Short Ratio2.45 Perf Half Y22.62%
Book/sh16.87 P/B3.76 EPS next Y11.54% ROA5.70% Target Price67.23 Perf Year32.26%
Cash/sh6.97 P/C9.10 EPS next 5Y13.32% ROE10.50% 52W Range43.13 - 64.75 Perf YTD42.94%
Dividend0.64 P/FCF34.69 EPS past 5Y18.40% ROI5.30% 52W High-1.92% Beta0.67
Dividend %1.01% Quick Ratio2.40 Sales past 5Y-6.10% Gross Margin41.30% 52W Low47.25% ATR0.66
Employees48000 Current Ratio3.00 Sales Q/Q0.80% Oper. Margin11.70% RSI (14)55.87 Volatility0.84% 0.95%
OptionableYes Debt/Eq0.38 EPS Q/Q-78.30% Profit Margin8.80% Rel Volume0.96 Prev Close63.38
ShortableYes LT Debt/Eq0.38 EarningsOct 25 BMO Payout32.80% Avg Volume2.33M Price63.51
Recom2.60 SMA200.81% SMA502.73% SMA20016.07% Volume1,672,109 Change0.21%
Aug-17-17Initiated Citigroup Neutral $63
Jul-28-17Reiterated UBS Neutral $57 → $62
Jul-27-17Reiterated Barclays Overweight $64 → $70
Jun-30-17Initiated Cantor Fitzgerald Overweight $70
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $55 → $58
Apr-04-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Jul-27-16Reiterated RBC Capital Mkts Sector Perform $47 → $50
Jun-06-16Resumed JP Morgan Neutral
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $40 → $47
Apr-14-16Upgrade Piper Jaffray Neutral → Overweight
Feb-03-16Reiterated RBC Capital Mkts Sector Perform $37 → $40
Nov-16-15Resumed Piper Jaffray Neutral $90 → $39
Aug-11-15Reiterated Barclays Overweight $43 → $45
Jul-30-15Downgrade Leerink Partners Outperform → Mkt Perform $82 → $40
Jul-13-15Reiterated RBC Capital Mkts Sector Perform $74 → $37
Jul-02-15Reiterated Barclays Overweight $80 → $43
Jul-02-15Downgrade BofA/Merrill Buy → Neutral
Jul-01-15Downgrade Credit Suisse Outperform → Neutral $75 → $39
Sep-22-17 01:38PM  Baxter International, Inc. : BAX-US: Dividend Analysis : September 01st, 2017 (record date) : By the numbers : September 22, 2017 Capital Cube
12:01PM  Gold Is Great Again Thanks to North Korea's Kim Jong-Un TheStreet.com
11:03AM  ETFs with exposure to Baxter International, Inc. : September 22, 2017 Capital Cube
Sep-21-17 12:07PM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Sep-20-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Sep-19-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Sep-18-17 08:30AM  Baxter Parenteral Nutrition Study Describes Lack of Quality Evidence That Fish Lipid Emulsions Significantly Improve Clinical Outcomes Business Wire
08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Sep-15-17 07:39AM  Partnerships, Collaborations to Strengthen Baxters IPS Segment Market Realist
Sep-14-17 06:18PM  Daniel Loeb's Third Point Returns Trounce S&P 500 Year to Date GuruFocus.com
04:36PM  Effect of Claris Injectables Acquisition on Baxters 2017 Growth Market Realist
03:06PM  Whats Expected of Baxter International in Fiscal 2017? Market Realist
01:14PM  Management Changes at Baxter International: What You Should Know Market Realist
09:38AM  Baxter (BAX) Hits a 52-Week High: What's Driving the Stock? Zacks
08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Sep-12-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
07:37AM  Understanding Baxters Updated 2020 Guidance: Wheres the Momentum? Market Realist
Sep-11-17 10:37AM  The Baxter International 2Q17 Story: Key Highlights Market Realist
10:05AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
09:07AM  Inside Baxter Internationals Stock Price Performance Market Realist
07:38AM  Behind Baxter Internationals Analyst Recommendations Market Realist
Sep-08-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Sep-07-17 11:30AM  Baxter Recognized as Responsible and Sustainable Business for 18th Consecutive Year by Dow Jones Sustainability Index (DJSI) Business Wire
Aug-31-17 08:30AM  Baxter and MATTER Healthcare Incubator Partner on Patient-Driven Innovation Business Wire
Aug-28-17 08:00AM  The Honor Society of Nursing, Sigma Theta Tau International, Names Dr. Therese S. Richmond as Its 2017 Episteme Award Recipient Business Wire
Aug-22-17 09:46AM  Baxter and ASPEN Announce Collaboration to Help Reduce Malnutrition Through Appropriate Use of Parenteral Nutrition Therapy Business Wire
08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-21-17 04:15PM  Baxter to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Business Wire
08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-18-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-16-17 07:54PM  Baxter International, Inc. Value Analysis (NYSE:BAX) : August 16, 2017 Capital Cube
08:19AM  Baxter International, Inc. breached its 50 day moving average in a Bullish Manner : BAX-US : August 16, 2017 Capital Cube
Aug-15-17 04:15PM  Baxter to Present at the Goldman Sachs 14th Annual European Medtech and Healthcare Services Conference Business Wire
Aug-14-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-12-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
05:15AM  Edited Transcript of BAX earnings conference call or presentation 26-Jul-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-11-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-10-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-09-17 08:00AM  See what the IHS Markit Score report has to say about Baxter International Inc. Markit
Aug-03-17 09:54AM  Baxter International, Inc. breached its 50 day moving average in a Bearish Manner : BAX-US : August 3, 2017 Capital Cube
08:00AM  CHF Solutions Commences Manufacturing Transition of Aquadex FlexFlow® System to its Minnesota Facility GlobeNewswire
Aug-01-17 06:27AM  Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways TheStreet.com
Jul-31-17 06:59PM  Cramer Remix: 3 red-hot stocks ready to roar higher CNBC
10:21AM  Zacks.com featured highlights: Baxter International, Coca-Cola FEMSA, S.A.B. de C.V., Banco Bilbao Vizcaya Argentaria, Fibria Celulose S.A. and Teekay Offshore Partners Zacks
Jul-28-17 10:16AM  Bet on These 5 GARP Stocks with Discounted PEG Ratio Zacks
07:20AM  Corporate News Blog - Sensus Healthcare Announces Achievement of Approval from China's FDA for SRT-100, the Non-Invasive Superficial Radiation Therapy ACCESSWIRE
Jul-27-17 03:39PM  Baxter International Inc.'s Revenue Growth Snoozes, but Check Out the Earnings Growth Motley Fool
07:00AM  Baxter Completes Acquisition of Claris Injectables, Expanding Generic Injectable Medicines Portfolio Business Wire
Jul-26-17 09:54PM  Baxter beats Street 2Q forecasts Associated Press
03:36PM  Daniel Loeb Discusses Baxter, Alibaba in Q2 Letter GuruFocus.com
12:41PM  Highlights From Third Point's Q2 Investor Letter: Baxter, Alibaba and BlackRock Benzinga
10:13AM  Baxter (BAX) Beats on Q2 Earnings, Raises Long-Term Outlook Zacks
08:47AM  Baxter International (BAX) Beats on Earnings And Sales in Q2 Zacks
07:15AM  Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 Business Wire
Jul-24-17 10:40AM  What to Expect from Baxter Internationals 2Q17 Earnings Market Realist
09:11AM  Discussing Baxter Internationals 2Q17 Revenue Estimates Market Realist
07:41AM  Analysts Views on Baxter International ahead of Its 2Q17 Results Market Realist
Jul-20-17 05:47PM  Abiomed in 2017: The Analysts View Market Realist
03:13PM  U.S. FTC approves Baxter's acquisition of Claris business with condition Reuters
10:00AM  Baxter Releases Annual Corporate Responsibility Report; Announces Progress Toward Social and Environmental 2020 Goals Business Wire
09:48AM  Baxter International (BAX) Q2 Earnings: What's in Store? Zacks
Jul-18-17 08:55AM  Baxter Declares Quarterly Dividend Business Wire
Jul-17-17 04:30PM  Baxter Appoints Cathy R. Smith to Its Board Business Wire
Jul-11-17 05:24PM  3 Excellent Value Picks Amid Political Grind in MedTech Zacks
12:17PM  Baxter Stock Jumps After Positive BMO Note, Then Retreats TheStreet.com
11:06AM  Baxter International Climbs On BMO Upgrade Barrons.com
09:30AM  Zacks.com featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuticals, Baxter International and A. O. Smith Zacks
Jul-07-17 08:56AM  Baxter and TAU Ink New Licensing Agreements through Ramot Zacks
Jul-06-17 08:00AM  Baxter, Ramot at Tel Aviv University and Tel Aviv Sourasky Medical Center Partner to Bring New Surgical Innovations Worldwide Business Wire
Jun-29-17 04:15PM  Baxter International Inc. to Host Second Quarter 2017 Financial Results Conference Call for Investors Business Wire
Jun-28-17 10:36AM  Baxter Is Focusing on Inorganic Growth Opportunities in 2017 Market Realist
09:06AM  Baxters Integrated Pharma Solutions May Be Solid Growth Driver Market Realist
07:37AM  In-Center Hemodialysis Poses Challenge to Baxters Renal Business Market Realist
Jun-27-17 10:38AM  Baxters Renal Business Continues to Be Key Growth Driver Market Realist
09:09AM  Baxter Expected to Report Significant Fall in Net Profit Margins Market Realist
07:43AM  Baxter Expected to Report Robust Revenue Growth in 2017 Market Realist
Jun-26-17 05:46PM  Analyst Recommendations for Baxter and Peers in June 2017 Market Realist
08:30AM  Baxter Announces DoseEdge Bi-Directional Integration with Epic in the Pharmacy Business Wire
Jun-22-17 09:30AM  Zacks.com featured highlights: American Woodmark, Lantheus Holdings, Baxter International, Apogee Enterprises and MAM Software Group Zacks
09:04AM  Baxter (BAX) Scales 52-Week High: What's Behind the Rally Zacks
Jun-16-17 02:35PM  2 Solid Medical Device Stocks to Scoop Up Right Away Zacks
Jun-15-17 09:25AM  Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line Zacks
Jun-14-17 08:30AM  Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline Business Wire
Jun-12-17 07:37AM  How Does Baxter Create Value for Its Shareholders? Market Realist
Jun-09-17 03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
02:05PM  Baxter International: Important Highlights in 1Q17 Market Realist
12:12PM  Analysts Latest Recommendations for Baxter International Market Realist
Jun-07-17 11:00AM  Baxter Announces U.S. FDA Approval and Commercial Launch of Ready-to-Use Clindamycin Injection in Saline Business Wire
Jun-05-17 04:05PM  Baxter Presents Data on Telehealths Role in Improving Peritoneal Dialysis Patient Care at ERA-EDTA 2017 Business Wire
08:00AM  New Data Demonstrates High Performance of HDx Enabled by THERANOVA, Baxters Novel Hemodialysis Therapy Business Wire
Jun-02-17 06:41PM  Daniel Loeb's Favorite Idea Spurs May Outperformance GuruFocus.com
Jun-01-17 11:43AM  Baxter International, Inc. : BAX-US: Dividend Analysis : June 02nd, 2017 (record date) : By the numbers : June 1, 2017 Capital Cube
10:26AM  3 Medical Device Stocks with Solid Potential to Buy Now Zacks
09:00AM  Baxter to Present Significant Data at ERA-EDTA 2017 to Help Advance New Standards of Renal Care Business Wire
May-31-17 09:37AM  Baxter International at a 52-Week High on Solid Product Line Zacks
09:15AM  Baxter and Mayo Clinic Launch Research and Development Collaboration to Transform Patient Care Business Wire
May-30-17 03:13AM  Baxter International (BAX) Up 6.7% Since Earnings Report: Can It Continue? Zacks
May-25-17 04:25PM  Tweedy Browne Sells Baxter, Cisco, 3M GuruFocus.com
11:29AM  Medtronic's focus on surgical products fuels profit beat Reuters
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STALLKAMP THOMAS TDirectorSep 05Option Exercise33.768,920301,12220,193Sep 06 05:46 PM
STALLKAMP THOMAS TDirectorSep 05Sale62.288,920555,53811,273Sep 06 05:46 PM
FORSYTH JOHN DDirectorAug 25Option Exercise29.569,440279,08638,124Aug 29 04:03 PM
FORSYTH JOHN DDirectorAug 25Sale61.769,440583,01428,684Aug 29 04:03 PM
Shapazian Carole JDirectorAug 24Option Exercise29.524,020118,67013,868Aug 25 04:02 PM
Shapazian Carole JDirectorAug 24Sale61.614,020247,6729,848Aug 25 04:02 PM
Accogli GiuseppeSVP, President, Global Bus.Aug 17Option Exercise37.3812,670473,60533,286Aug 18 04:08 PM
Accogli GiuseppeSVP, President, Global Bus.Aug 17Sale60.9612,670772,36320,616Aug 18 04:08 PM
Third Point LLCDirectorJun 01Sale59.505,000,000297,500,00041,001,790Jun 02 05:13 PM
Shapazian Carole JDirectorMay 23Sale57.922,618151,6359,848May 24 05:00 PM
Shapazian Carole JDirectorMay 09Option Exercise33.773,760126,97516,226May 10 04:16 PM
Shapazian Carole JDirectorMay 09Sale55.893,760210,14612,466May 10 04:16 PM
Eyre Brik VSr VP, President, AmericasMay 08Option Exercise36.71130,7324,799,204176,148May 09 05:16 PM
Eyre Brik VSr VP, President, AmericasMay 08Sale55.69130,7327,280,46545,416May 09 05:16 PM
STALLKAMP THOMAS TDirectorMay 05Option Exercise28.698,080231,82215,593May 09 04:25 PM
STALLKAMP THOMAS TDirectorMay 05Sale55.7610,698596,49011,273May 09 04:25 PM
STROUCKEN ALBERT P LDirectorApr 10Option Exercise30.734,280131,52425,667Apr 12 06:01 PM
STROUCKEN ALBERT P LDirectorApr 10Sale52.804,280225,98421,387Apr 12 06:01 PM
GAVIN JAMES R IIIDirectorMar 29Option Exercise30.734,280131,52434,980Mar 30 04:12 PM
GAVIN JAMES R IIIDirectorMar 29Sale51.724,280221,36230,700Mar 30 04:12 PM
Third Point LLCDirectorFeb 28Sale50.355,901,767297,153,96846,001,790Mar 01 11:25 AM
HELLMAN PETER SDirectorFeb 22Option Exercise30.734,280131,52424,420Feb 23 04:23 PM
HELLMAN PETER SDirectorFeb 22Sale49.814,280213,18720,140Feb 23 04:23 PM
FORSYTH JOHN DDirectorFeb 08Option Exercise30.734,280131,52431,338Feb 10 04:02 PM
FORSYTH JOHN DDirectorFeb 08Sale48.354,280206,93827,058Feb 10 04:02 PM
Shapazian Carole JDirectorFeb 06Option Exercise30.734,280131,52413,507Feb 08 04:14 PM
Shapazian Carole JDirectorFeb 06Sale48.234,280206,4249,227Feb 08 04:14 PM
STORM KORNELIS J.DirectorNov 18Option Exercise30.734,280131,52425,208Nov 22 04:27 PM
STORM KORNELIS J.DirectorNov 18Sale47.104,280201,58820,928Nov 22 04:27 PM
open in yahoo | open in reuters | open in google